Exploring Life Factors in Multiple Sclerosis Patients
Care in Multiple Sclerosis (MS)
Recruiting
Observational Study
Multiple Sclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- NYU Langone Health · Other
Who this trial is looking for
This trial is looking for individuals with relapsing-remitting multiple sclerosis, particularly from Black, Hispanic, or low-income backgrounds. Participants will take part in interviews and assessments to understand how childhood experiences and environment affect their health and quality of life.
Are You a Good Fit for This Trial?
You may be able to join if
- I am aged 18-29 years
- I have been diagnosed with relapsing-remitting multiple sclerosis
- I self-identify as Black, Hispanic, or impoverished
- I am fluent in English or Spanish
- My multiple sclerosis started after I turned 18 or before I turned 18 and I am now 18-25 years old
- I have had multiple sclerosis for less than 8 years
You may not be able to join if
- I have primary or secondary progressive multiple sclerosis
- I cannot give my consent to participate
- I have had a relapse of MS within the last 30 days
- I have another major neurologic or psychiatric illness
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This study is structured around three main aims.
In Aim 1, investigators will conduct community-based participatory research (CBPR) to develop culturally tailored methods to assess childhood adversity in multiple sclerosis (MS).
Aim 2 will investigate the impact of childhood adversity on MS outcomes among individuals with relapsing-remitting MS (RRMS), among whom 70% belong to a group historical…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Aim 1 -
* aged ≥18-29 years
* diagnosis of RRMS (Fulfill international criteria for relapsing remitting (RRMS))
* 70% self-identifying as a Black, Hispanic, or poverty-impacted (up to 138% of the federal poverty level) individual,and
* fluent in English or Spanish.
Aim 2 -
* …
Contacts